Establishment of biological cut-off values for predicting resistance to therapy

Details for Australian Patent Application No. 2002212344 (hide)

Owner Virco BVBA

Inventors Hertogs, Kurt; Harrigan, Richard P; Larder, Brendan

Agent Shelston IP

Pub. Number AU-B-2002212344

PCT Pub. Number WO02/33402

Priority 60241836 20.10.00 US

Filing date 22 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 17 May 2007

International Classifications

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

17 May 2007 Application Accepted

  Published as AU-B-2002212344

13 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002212345

2002212343